Hepatocellular carcinoma: Where are we in 2018?-Reference-Cited by-同舟云学术

Hepatocellular carcinoma: Where are we in 2018?

Published:2018-11 Issue:11 Volume:55 Page:450-503
ISSN:0011-3840
Container-title:Current Problems in Surgery
language:en
Short-container-title:Current Problems in Surgery

Author:

Chapman William C.,Korenblat Kevin M.,Fowler Kathryn J.,Saad Nael,Khan Adeel S.,Subramanian Vijay,Doyle Maria B. Majella,Dageforde Leigh Anne,Tan Benjamin,Grierson Patrick,Lin Yiing,Xu Min,Brunt Elizabeth M.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference231 articles.

1. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

2. Randomized controlled trial of screening for hepatocellular carcinoma;Zhang;J Cancer Res Clin Oncol,2004

3. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?;Poustchi;Hepatology,2011

4. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival;Leykum;Clin Gastroenterol Hepatol,2007

5. Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands;van Meer;J Hepatol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis;Medicinal Chemistry;2022-12

2. Symptomatic pituitary metastasis from hepatocellular carcinoma: a case report and literature review;All Life;2021-01-01

3. Sodium Alginate Microspheres Tissue Metabolism and Correlation Between Interventional Treatment of Liver Cancer Using Alginate Microspheres and Prognosis of Liver Cancer;Journal of Biomaterials and Tissue Engineering;2019-07-01